This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Traces of a brain protein in blood could soon lead to a test that could diagnose chronic traumatic encephalopathy (CTE) during a person's lifetime. CTE is a degenerative brain disease best known for affecting football players.
Right now, CTE can only be diagnosed via autopsy after death. One recent autopsy-based study found that nearly 75% of deceased former NFL players had been affected by CTE.
The illness is linked to repeat head injury and can lead to cognitive impairment, behavioral changes, mood swings and dementia.
A blood-based test that could spot CTE while players are still alive could be "a game changer," said study co-senior author Michael Alosco, co-director of clinical research at Boston University's CTE Center.
The test is not yet approved by the U.S. Food and Drug Administration (FDA).
"We are still in the discovery phase, and it's a small sample size, but if future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy and open the doors to clinical trials and treatment," Alosco said in a university news release.
The researchers based their findings on blood tests conducted with 21 former American football players while they were still alive. All had donated their brains for research, and 18 of the players' brains revealed the presence of CTE.
The blood test is designed to spot traces of a brain protein abbreviated as eMTBR-tau.
Source link







